[{"Assets_0_Q2_USD":66243000.0,"CommonStockSharesOutstanding_0_Q2_shares":57978725.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10741000.0,"NetIncomeLoss_1_Q2_USD":-10971000.0,"NetIncomeLoss_2_Q2_USD":-21785000.0,"StockholdersEquity_0_Q2_USD":40745000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]